SciShow
Chemo Sucks. Science Is Changing That
We use chemotherapy because it works, but no one has ever come home from chemo treatment and gone "That was fun!" Let's look at the new targeted therapies and personalized treatments for cancer that doctors are developing for clinical use.
SciShow
Jimmy Carters Cancer Cure
In August 2015, Jimmy Carter announced that he had a form of cancer that spread to his liver and brain. A few months later he reported the cancer was gone. How?
SciShow
The Secret to Becoming Immune to Mosquito Bites
Like most allergies, you can become immune to mosquito bites, but it might not be worth it.
SciShow
How We Could Beat Childhood Peanut Allergies | SciShow News
More and more kids are avoiding peanut butter due to life threatening allergies, but we could make it so that no kid goes without a PBJ
Healthcare Triage
Cancer Research Spotlighted in Nobel Prize for Medicine
We've been talking a lot about the state of cancer research in the HCT Podcast, and now the Nobel prize in medicine is going to cancer researchers. So that's pretty cool. Check out some of the amazing (and amazingly expensive) treatments...
Next Animation Studio
2018 Nobel Prize for Medicine awarded to duo's work on cancer immunotherapy
The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their immunotherapy work in the fight against cancer.
The Wall Street Journal
Beating Cancer
At the 2020 WSJ Health Forum, Genetech CEO Alexander Hardy spoke with Health & Science Deputy Bureau Chief Jonathan D. Rockoff about big pharma, biotech and where the next big cancer breakthrough may come from.
STAT
Searching for the right clinical trial
Rachel Lefebvre has stage 4 colon cancer and is searching for an immunotherapy treatment that will combat her tumors.
Next Animation Studio
Woman's advanced stage breast cancer eradicated with immunotherapy
A woman's advanced stage breast cancer that had spread to other parts of her body was cured using immunotherapy.
Globalive Media
Beyond Innovation: Episode 21
An algorithm becomes a book critic, a robot imitates a fruit fly and a startup pioneers a new way to fight cancer. Plus, Michael and Anthony speak with prolific inventor Nathan Myhrvold about metamaterials that possess strange yet useful...
Curated Video
Possible breakthrough on lung cancer
Research into the treatment of lung cancer has achieved a possible breakthrough - after a new study showed survival times were nearly doubled for some patients - by combining the use of immunotherapy drugs with chemotherapy. Oncologists...
Curated Video
Cuba's Cutting-Edge Pharmaceuticals
Cuba has developed a vaccine against lung cancer and Americans are traveling through Canada to get access to the drug, but that could soon change.
Press Association
'Exciting' mRNA jab for melanoma being tested in British patients
The world's first mRNA jab to cure melanoma - which also has the potential to stop lung, bladder and kidney cancer - is being tested in British patients. The anti-cancer jab is custom-built for each person in as little as eight weeks and...
Curated Video
Vaccine being developed to fight tumors in liver cancer patients
The "personalized" vaccine, when given with another cancer treatment, is showing promising results in shrinking tumors.
Bloomberg
Insights From the World's Biggest Cancer Conference
Jun.08 -- Dr. Drew Pardoll, director of the Bloomberg-Kimmel Cancer Institute for Cancer Immunotherapy, and Bloomberg Intelligence's Asthika Goonewardene share insights from the ASCO cancer conference. They spoke Thursday on "Bloomberg...
Press Association
Alternative to chemotherapy being developed in Northern Ireland
An experimental cancer treatment is providing an alternative to chemotherapy in Northern Ireland. It is an alternative to chemotherapy, which attacks all rapidly-dividing cells even if they're healthy.
AFP News Agency
CLEAN : Cervical cancer survivor tells about miraculous new therapy
CLEAN : Cervical cancer survivor tells about miraculous new therapy
Bloomberg
Bloomberg Intelligence on the Frontiers of Cancer Research
Oct.13 -- Bloomberg Intelligence’s Sam Fazeli explained what could potentially revolutionize cancer therapy over the next 10 years.
Bloomberg
Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
Mar.24 -- Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan to sell the drug for $13,000 a month. Merck KgaA CEO Stefan Oschmann speaks...
Bloomberg
Kite Pharma CEO Belldegrun on Cancer Drugs, Prices
Jan.12 -- Kite Pharma CEO Arie Belldegrun discusses the debate over over drug pricing and the company's products. He spoke with Erik Schatzker on Jan. 10 from the JPMorgan Health Care Conference on "Bloomberg Markets."
Bloomberg
ETF Growth Opportunities in Chinese Biotech
Jun.19 -- Bloomberg's Eric Balchunas and Scarlet Fu break down the Loncar China Biopharma ETF (ticker: CHNA) with Brad Loncar, CEO of Loncar Investments. They discuss growth prospects in the space.
Bloomberg
Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in Trial
Moderna Inc.'s experimental personalized cancer vaccine reduced the risk of relapse or death from melanoma when combined with Merck & Co.'s Keytruda in a mid-stage trial. The combination cut the death risk or recurrence of the skin...
Press Association
Man with terminal cancer cleared of disease thanks to UK drug trial
A man told he had less than 12 months to live is now cancer-free thanks to a UK trial of a new drug regime. Robert Glynn, 51, a welder from Worsley in Greater Manchester, said he “wouldn’t be here” if it were not for the astonishing...